
The acquisition brings Gallant’s experimental stem cell treatments for chronic gingivostomatitis and osteoarthritis in dogs and cats into Dechra’s portfolio.
Participants in the 2011 Bayer Veterinary Care Usage Study were asked what they most wanted from their veterinarians. Here's what they said:

